A. Lakhani

526 total citations
16 papers, 356 citations indexed

About

A. Lakhani is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, A. Lakhani has authored 16 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in A. Lakhani's work include Chronic Lymphocytic Leukemia Research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). A. Lakhani is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). A. Lakhani collaborates with scholars based in United Kingdom, United States and Portugal. A. Lakhani's co-authors include Daniel Catovsky, Patrick Thornton, Estella Matutes, Timothy Perren, Garry Forgeson, A Nandi, A. Zuiable, P H Mackie, H. Grech and Rajeev Joshi and has published in prestigious journals such as Blood, Cancer Research and British Journal of Haematology.

In The Last Decade

A. Lakhani

16 papers receiving 339 citations

Peers

A. Lakhani

GENET

HEMAT

PFM

ONCOL

IMMUN

Michihiko Masuda Japan

Gradimir Janković Serbia

Sheryl L. Asplund United States

CE Litz United States

Keiren Kirkland United Kingdom

Esperanza Tuset Spain

Hasan S. Khalidi United States

D. K. Hossfeld Germany

Masanobu Kasai Japan

Aïssata Tolo Ivory Coast

Michihiko Masuda Japan

A. Lakhani

111 ×0.6

GENET

175 ×1.0

HEMAT

86 ×0.8

PFM

117 ×1.4

ONCOL

98 ×1.2

IMMUN

Citations per year, relative to A. Lakhani A. Lakhani (= 1×) peers Michihiko Masuda

Countries citing papers authored by A. Lakhani

Since Specialization

Citations

This map shows the geographic impact of A. Lakhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lakhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lakhani more than expected).

Fields of papers citing papers by A. Lakhani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lakhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lakhani. The network helps show where A. Lakhani may publish in the future.

Co-authorship network of co-authors of A. Lakhani

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lakhani. A scholar is included among the top collaborators of A. Lakhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lakhani. A. Lakhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Lakhani, A., et al.. (2014). Clodronate exerts an anabolic effect on articular chondrocytes mediated through the purinergic receptor pathway. Osteoarthritis and Cartilage. 22(9). 1327–1336. 21 indexed citations

2.

Lakhani, A., Rong Guo, Xiuzhen Duan, et al.. (2012). Abstract PD10-02: Metabolic syndrome and recurrence within the 21-gene recurrence score assay risk categories in lymph node negative breast cancer. Cancer Research. 72(24_Supplement). PD10–2. 3 indexed citations

3.

Win, Nay, et al.. (2007). Mixed-type autoimmune haemolytic anaemia: Unusual cases and a case associated with splenic T cell angioimmunoblastic non-Hodgkins lymphoma. Hematology. 12(2). 159–162. 11 indexed citations

4.

Win, Nay, et al.. (2007). Mixed-type autoimmune haemolytic anaemia: Unusual cases and a case associated with splenic T cell angioimmunoblastic non-Hodgkins lymphoma. Hematology. 12(2). 159–162. 7 indexed citations

5.

Swansbury, John, Bruno Cazin, Robin Ireland, et al.. (2005). Clinical Outcome of Stem Cell Transplantation(SCT) in Patients with T Cell Prolymphocytic Leukaemia(T-PLL) Previously Treated with Alemtuzumab: A Multicentre Experience.. Blood. 106(11). 1127–1127. 4 indexed citations

6.

Thornton, Patrick, Estella Matutes, Andrew G. Bosanquet, et al.. (2003). High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities. Annals of Hematology. 82(12). 759–765. 76 indexed citations

7.

Thomas, Ranjit, Isabel Ribeiro, Patricia Shepherd, et al.. (2002). Spontaneous clinical regression in chronic lymphocytic leukaemia. British Journal of Haematology. 116(2). 341–345. 3 indexed citations

8.

Ribeiro, Isabel, Patricia Shepherd, Peter Johnson, et al.. (2002). Spontaneous clinical regression in chronic lymphocytic leukaemia. British Journal of Haematology. 116(2). 341–345. 26 indexed citations

9.

Thornton, Patrick, Michael R. Hamblin, J Treleaven, et al.. (1999). High Dose Methyl Prednisolone in Refractory Chronic Lymphocytic Leukaemia. Leukemia & lymphoma. 34(1-2). 167–170. 31 indexed citations

10.

Zomas, Athanasios, Judith Marsh, Neil Harrison, et al.. (1995). Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anemia. Annals of Hematology. 71(1). 49–51. 14 indexed citations

11.

Rhee, Frits van, Fang Lin, Nicholas C.P. Cross, et al.. (1994). Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia.. PubMed. 14(4). 609–12. 44 indexed citations

12.

Kaczmarski, Richard, et al.. (1993). A pilot study of low‐dose recombinant human granulocyte‐macrophage colony‐stimulating factor in chronic neutropenia. British Journal of Haematology. 84(2). 338–340. 11 indexed citations

13.

Gore, Martin, R Powles, A. Lakhani, et al.. (1989). Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide. Cancer Chemotherapy and Pharmacology. 23(6). 373–376. 28 indexed citations

14.

Millar, B. C., et al.. (1988). A simple method for culturing myeloma cells from human bone marrow aspirates and peripheral blood in vitro. British Journal of Haematology. 69(2). 197–203. 19 indexed citations

15.

Powles, R, A. Lakhani, S Milan, et al.. (1988). Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission.. PubMed. 3(1). 21–9. 57 indexed citations

16.

Lakhani, A., R Powles, A Nandi, et al.. (1987). Bone marrow transplantation—The Marsden experience. Hematological Oncology. 5(4). 245–254. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact